Tianjin Zhongxin Pharmaceutical Group Co.,Ltd Fundamental Rankings

This page is comprehensive fundamental data for Tianjin Zhongxin Pharmaceutical Group Co.,Ltd. Fundamentals are ordered by how Tianjin Zhongxin Pharmaceutical Group Co.,Ltd ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Cash paid for other financing activities18,487,630,3211.4493722015-06-30historic
Proceeds from sell of investment13,278,273,9781.0409862015-06-30historic
Cash inflows from financing activities19,789,369,5681.5514382015-06-30historic
Held to maturity investment235,645,8450.01847212015-06-30historic
Selling expenses696,693,8320.05462442015-06-30historic
Net change in cash837,021,1110.065621172015-06-30historic
Other current liabilities167,600,0000.013141292015-06-30historic
Investment income from associate and joint venture12,611,4039.9E-41542015-06-30historic
Long term equity investment532,581,4440.041751632015-06-30historic
Cash paid for taxes273,948,9250.021482322015-06-30historic
Net income242,898,8100.019042442015-06-30historic
Total comprehensive income258,650,1850.020282532015-06-30historic
Total profit289,870,7750.022722582015-06-30historic
Deferred tax assets88,122,1410.006912642015-06-30historic
Other payables449,663,2410.035252682015-06-30historic
Operating profit263,854,6280.020692692015-06-30historic
Revenue3,361,680,9280.263552742015-06-30historic
Net cashflow from financing activities642,022,7940.050332762015-06-30historic
Notes receivable250,107,4520.019612832015-06-30historic
Total cost of goods sold3,133,851,9080.245682852015-06-30historic
Payroll payable75,718,3830.005942962015-06-30historic
Prepayment278,181,3700.021813092015-06-30historic
Net cash and cash equivalents ending balance1,394,082,9270.109293212015-06-30historic
Long term accounts payable3,949,4703.1E-43212015-06-30historic
Cash inflows from operating activities3,031,777,8070.237683602015-06-30historic
Cash outflows from operating activities2,806,294,2600.223842015-06-30historic
Net cash flows from investing activities-30,485,229-0.002393852015-06-30historic
Comprehensive income attributable to minority shareholders4,035,0993.2E-43862015-06-30historic
Minority interests gain4,035,0993.2E-43892015-06-30historic
Minority interest180,616,7810.014164142015-06-30historic
Accounts payable702,888,7490.05514612015-06-30historic
Inventories1,011,172,1980.079274792015-06-30historic
Short term borrowings664,000,0000.052065162015-06-30historic
Other current assets96,945,1410.00765242015-06-30historic
Other receivables68,264,8600.005355722015-06-30historic
Financial expenses21,929,2030.001726022015-06-30historic
Capital reserve1,307,480,1450.10256152015-06-30historic
Refunds of taxes2,201,7531.7E-46342015-06-30historic
Total liabilities2,515,838,1090.197236342015-06-30historic
Total liabilities and equity6,418,045,9090.503156382015-06-30historic
Cash paid for dividends, profits or interests81,716,4540.006416402015-06-30historic
Interests payable932,0507.0E-56542015-06-30historic
Intangible assets188,674,9020.014796762015-06-30historic
Non-operating loss832,2907.0E-57142015-06-30historic
Total non-current assets2,066,183,7550.161987292015-06-30historic
Disposal of fixed assets and others80,7641.0E-57472015-06-30historic
Fixed assets777,435,8680.060957622015-06-30historic
Purchases of fixed assets and others40,238,1510.003159152015-06-30historic
Diluted eps00.012592015-06-30historic